Ad
related to: european hematology association
Search results
Read Why Forma Therapeutics' Current Price Level Is 'Attractive Entry Point'
Benzinga via Yahoo Finance· 2 years agoDuring the European Hematology Association (EHA) conference, Forma Therapeutics Holdings Inc...
HC Wainwright Sees This Small-Cap Biotech As Undervalued, Underappreciated
Benzinga via Yahoo Finance· 2 years agoAt the European Hematology Association (EHA) meeting, Oncternal Therapeutics Inc (NASDAQ: ONCT)...
New Data Show Roche's Self-Administered Blood Disorder Candidate Achieves Disease Control
Benzinga via Yahoo Finance· 12 months agoRoche Group Holdings AG's (OTC: RHHBY) data from the global phase 3 COMMODORE 1 and 2 studies...
LAVA Therapeutics Highlights Encouraging Clinical Updates on Lead Cancer Program
Benzinga via Yahoo Finance· 2 years agoLAVA Therapeutics N.V. (NASDAQ: LVTX) hosted a clinical update call focused on initial Phase 1/2a...
Why Shares of Omeros Dropped on Monday
Motley Fool· 12 months agoShares of Omeros (NASDAQ: OMER) were down 12.9% early Monday afternoon after the clinical-stage biopharmaceutical company released a presentation it made...
Seagen's Adcetris/Immunotherapy Combo Achieves 98% Overall Response Rate in Early-Stage Lymphoma...
Benzinga via Yahoo Finance· 12 months agoSeagen Inc (NASDAQ: SGEN) announced updated efficacy and safety results from Part C of phase 2...
Why Bluebird Bio Skyrocketed Today
Motley Fool· 2 years agoShares of Bluebird Bio (NASDAQ: BLUE) had popped by more than 34.3% at 10:58 ET Friday morning amid a wider rally in the cell and gene therapy segments of the biotech industry. The jump in its ...
Roche (RHHBY) Announces Positive Results From PNH Studies
Zacks via Yahoo Finance· 12 months agoRoche (RHHBY) crovalimab achieves disease control in paroxysmal nocturnal hemoglobinuria patients in...
Why Is Small-Cap Cancer Focused Vincerx Pharma Stock Plummeting On Tuesday?
Benzinga via Yahoo Finance· 2 months agoOn Monday, Vincerx Pharma Inc (NASDAQ:VINC) presented preliminary Phase 1 data for VIP236 and...
Editas Medicine, Inc. (NASDAQ:EDIT) Q2 2023 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 10 months agoEditas Medicine, Inc. (NASDAQ:EDIT) Q2 2023 Earnings Call Transcript August 2, 2023 Editas Medicine,...
